Yashpal Singh Malik

ORCID: 0000-0002-2832-4854
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Viral gastroenteritis research and epidemiology
  • Animal Virus Infections Studies
  • Animal Disease Management and Epidemiology
  • Viral Infections and Immunology Research
  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Vectors
  • Vector-Borne Animal Diseases
  • Virus-based gene therapy research
  • COVID-19 Clinical Research Studies
  • Zoonotic diseases and public health
  • Virology and Viral Diseases
  • Microbial infections and disease research
  • COVID-19 epidemiological studies
  • Mosquito-borne diseases and control
  • Hepatitis Viruses Studies and Epidemiology
  • Herpesvirus Infections and Treatments
  • Agricultural Science and Fertilization
  • Viral Infections and Outbreaks Research
  • Respiratory viral infections research
  • Salmonella and Campylobacter epidemiology
  • Agricultural Practices and Plant Genetics
  • vaccines and immunoinformatics approaches
  • Veterinary Practice and Education Studies
  • Plant Virus Research Studies
  • Influenza Virus Research Studies

Guru Angad Dev Veterinary and Animal Sciences University
2020-2024

Indian Veterinary Research Institute
2015-2024

Integral University
2024

Instituto Evandro Chagas
2023

Technology Innovation Institute
2023

National Institute of High Security Animal Diseases
2023

Washington State University
2023

ICMR-National Institute of Virology
2023

Aurobindo Pharma (India)
2022

Indian Council of Agricultural Research
2015-2022

The rapidly spreading, highly contagious and pathogenic SARS-coronavirus 2 (SARS-CoV-2) associated Coronavirus Disease 2019 (COVID-19) has been declared as a pandemic by the World Health Organization (WHO). novel SARS-CoV-2 enters host cell binding of viral surface spike glycoprotein (S-protein) to cellular angiotensin converting enzyme (ACE2) receptor. virus specific molecular interaction with represents promising therapeutic target for identifying antiviral drugs. repurposing drugs can...

10.3389/fimmu.2020.01664 article EN cc-by Frontiers in Immunology 2020-07-10

Abstract Background Tuberculosis represents a serious public health problem and significant diagnostic therapeutic challenge worldwide. Molecular techniques are crucial in the World Health Organization’s new tuberculosis control strategy. This study aims to evaluate performance of GeneXpert MTB/RIF (Cepheid Sunnyvale, CA, United States) diagnosis extra-pulmonary then compare it’s detecting Rifampicin resistance GenoType MTBDRplus (HAIN Life Sciences, Nehren, Germany). Methods Samples from...

10.1186/s12879-019-4687-7 article EN cc-by BMC Infectious Diseases 2019-12-01
Coming Soon ...